SWOG S0221: A Phase III Trial Comparing Chemotherapy Schedules in High-Risk Early-Stage Breast Cancer

PURPOSE: To determine the optimal dose and schedule of anthracycline and taxane administration as adjuvant therapy for early-stage breast cancer. PATIENTS AND METHODS: A 2 × 2 factorial design was used to test two hypotheses: (1) that a novel continuous schedule of doxorubicin-cyclophosphamide was s...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Clin Oncol
Hlavní autoři: Budd, George T., Barlow, William E., Moore, Halle C.F., Hobday, Timothy J., Stewart, James A., Isaacs, Claudine, Salim, Muhammad, Cho, Jonathan K., Rinn, Kristine J., Albain, Kathy S., Chew, Helen K., Burton, Gary V., Moore, Timothy D., Srkalovic, Gordan, McGregor, Bradley A., Flaherty, Lawrence E., Livingston, Robert B., Lew, Danika L., Gralow, Julie R., Hortobagyi, Gabriel N.
Médium: Artigo
Jazyk:Inglês
Vydáno: American Society of Clinical Oncology 2015
Témata:
ORIGINAL REPORTS
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4268253/
https://ncbi.nlm.nih.gov/pubmed/25422488
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2014.56.3296
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky